PYLARIFY TruVu™ (piflufolastat F 18) Injection

2026.03.06 PYLARIFY TruVu PR Image

PYLARIFY TruVu™ (piflufolastat F 18) Injection, a new formulation of Lantheus' widely-used U.S. market-leading PSMA PET imaging agent that combines the diagnostic performance of PYLARIFY® (piflufolastat F 18) with the potential for larger batches and greater patient availability.

Format

PNG

Source

Lantheus Holdings, Inc.

Téléchargements